Rs Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.s.

This early-phase trial tested a new drug called RS-0139 in 16 people with advanced solid tumors that had stopped responding to standard treatments. The drug is designed to target tumors specifically, and the main goals were to find a safe dose and understand how the body processe…